with the Use of RABS and Isolators Barcelona, Spain October 27, 2015

Similar documents
Glove Management. PDA Ireland Chapter Dublin 04 th Oct Dr. Aidan Harrington DPS Group

1 5 2 Definition of Isolator Technology Isolator Types and Applications 3 Critical Design Considerations 4 Biodecontamination Conclusion and Summary 2

Retrofitting RABS to existing aseptic filling lines

IMA SpA. Advancements in Isolation Technology for Aseptic Filling. Marco Preus, July 2016

Whitepaper Technical Opinion: Grade A - Air Supply and Local Protection

CTG Certification Protocol -- Version 3.0 SUMMARY

H 2 O 2 Bio-Decontamination and Aseptic Transfer of Heat Sensitive Materials Sergio Mauri, Director, Global Marketing and Business Intelligence

LIGHTHOUSE. Stopper Pop-Up and the Effects on. Container Closure of Sterile Vials. Application Note 101 LIGHTHOUSE

OPERATOR, PRODUCT AND ENVIRONMENTAL PROTECTION

OPERATOR, PRODUCT AND ENVIRONMENTAL PROTECTION

Facility design for containment. Gordon Farquharson, July 2016

Presented by ARAMSCO

STANDARD OPERATING PROCEDURES DIVISION OF COMPARATIVE MEDICINE UNIVERSITY OF SOUTH FLORIDA

EuroBioConcept s.a.s Hospital Pharmacy Isolator Systems

Transfer Procedures. By the end of this chapter, you will be able to: The Transfer Process. Chapter 12

Laboratory Safety Training. Environmental Health and Safety

ProSys Laboratory Analytical Isolators

Biography. Cleaning & Disinfection. Overview of Veltek Associates, Inc. Peter Koger Veltek Associates Inc.

From the heart of safety the essence of innovation

Aseptic processing. the starting material to the finished product, should be controlled by Validation Control of the aseptic process

OEL LIMITS: Products are classified according to hazards levels that correspond to these five OEL levels as shown in the chart below :

Biosafety Level 2 (BSL2) Laboratory Safety Inspection Checklist

Submission of comments on Revision of Annex 1: Manufacture of Sterile Medicinal Products

DESIGN AND INSTALLATION CONSIDERATIONS FOR TSI AEROTRAK VHP-RESISTANT REMOTE PARTICLE COUNTERS

Int r oduct ion t o Int egr it y Tes t ing Theor y

Aseptic Techniques. Techniques for Sterile Compounding. Pharmacy Technician Training Systems Passassured, LLC

BATCH MANUFACTURING RECORD FOR PRODUCT X,

GREIG FILTERS, INC. OPERATION MANUAL

Sole reliance for sterility or other quality aspects must not be placed on finished product test.

Webinar Expert Module 1: Garment Logistics and Gowning. Dupont September GOP-Innovations

BIOSAFETY SELF AUDIT PRINCIPAL INVESTIGATOR/PERMIT HOLDER: CONTAINMENT LEVEL: 1 2 (Shaded) RISK GROUP: 1 2 AUDIT TO BE COMPLETED BY (DATE):

CCM Approval: IACUC Approval:

OCCUPATIONAL SAFETY AND ENVIRONMENTAL HEALTH GUIDELINE

Walk in Modular Material Transfer Chamber Including Integration of a Bioquell Clarus L2 hydrogen peroxide vapour (HPV) generator

Sterisil Ac+ Installation & Operating Manual

1. The laboratory supervisor must enforce the institutional policies that control access to the laboratory.

STANDARD OPERATING PROCEDURES DIVISION OF COMPARATIVE MEDICINE UNIVERSITY OF SOUTH FLORIDA

Flexible Containment Solutions Guide

Aseptic Vial and Syringe Filling Narlin B. Beaty, Ph.D. Adelaide Nye

Discussion and guidance on the definition and qualification of porous loads

SomnoSuite FAQ. Setup. Calibration 4. What are the calibration requirements for the SomnoSuite? Settings

Aseptic Processing Achieving Sterility by Design

In summary, the ISPE comments suggest the following additional improvements to the modified Annex 1 document:

BD Cytopeia Fluidic Kit User s Guide

TJF-Q180V Cleaning and Disinfection Checklist

CultiBag STR. Disposable CultiBags

Laboratory Safety Review Checklist One Shields Ave Davis, CA Phone: (530) Fax: (530)

NuAire Model NU PR797 Positive Pressure Recirculating Compounding Aseptic Isolator Performance Evaluation Compliance to USP797

Ad Hoc GMP Inspections Services Group EC GUIDE TO GOOD MANUFACTURING PRACTICE REVISION TO ANNEX 1

In Vessel Composter Installation & Commissioning Manual

Safety Procedures on Vacating Premises

NUS Safety & Health Guidelines Procedure No: OSHE/SOP/GL/08

Laboratory Safety Inspection Checklist

PERFORM Operating Document

Management Plan for Liquid Chlorine ISD #535

3M Steri-Vac Sterilizer/Aerator GSX Series. For Life Science Applications. Product. Profile

Parallel Session 1A Sterile Manufacture. Denise Coakley. GMP Conference 12 th November 2014

Gerard Sheridan Inspector

Standard Flexel 3D bioprocessing bags for Palletank

Idaho Fire Service Technology Fire Fighter II

The primary purpose of laboratory fume hoods is to keep toxic or irritating vapors out of the general laboratory working area.

Annex 1: Manufacture of Sterile Medicinal Products

TEMPLE UNIVERSITY ENVIRONMENTAL HEALTH AND RADIATION SAFETY

Summary of BCCA Pharmacy Practice Standards for Hazardous Drugs

TJF-Q180V Cleaning and Disinfection Checklist

HAZCOMM & Lab Safety College of Dental Medicine Research Safety Specialist Environmental Health and Safety

Aseptic Formulation and Filling Using Isolator Technology Frank DeSantis, Kent Amsberry, Jeff L. Folks,* Atsushi Yamamori, and James Akers

Semi-annual BRD Checklist. Inspection Location(s) P.I. Name. Office Telephone : Contact Telephone : Department. Survey Date : Reviewed Date :

EVALUATING KEGGING OPERATIONS: SEEING INTO THE BLACK BOX. Eric Johann Samp, Ph.D. Chris Nimptsch

Laboratory Safety Review Checklist One Shields Ave Davis, CA Phone: (530) Fax: (530)

VALITEQ DMS v2.o Document Management Software Tutorial

PERFORM Operating Document

LIGHTHOUSE Instruments, Biomatrix Building, Kruislaan 406, 1098 NX Amsterdam, The Netherlands;

RECOMBINATE. [Antihemophilic Factor (Recombinant)] (For intravenous use only)

BERNER FlowSafe I-[MaxPro] ³

Hose Reel Enclosure Retrofit Kit

Installation/Care/Use Manual

Seed Treatment Safety and Regulations Crop Protection Perspective. Chip Witcher / Staff Industrial Hygienist / Syngenta Crop Protection

UNITYPOINT HEALTH - MARSHALLTOWN Marshalltown, Iowa PHARMACY POLICY AND PROCEDURE

Water Mist Systems Inspection, Testing, and Maintenance of Water Mist Systems

Instructions for Cleaning Equipment: Low Level Disinfection. Beaumont Hospital, Dearborn Infection Prevention & Control 2017

Laboratory and Satellite Rodent Housing

Name of Company Involved. Exact or Estimated Value. Accepted / Refused

Laminar Flow LFGI (CAI or CACI) User Manual

with O 2 Controller Instruction Manual

NuAire Model NU NR797 Negative Pressure Recirculating Compounding Aseptic Containment Isolator Performance Evaluation Compliance to USP797

INSTALLATION, CARE & USE MANUAL. EMASMB & LMASMB Surface Mount Bottle Filling Stations

INSTALLATION AND OPERATION MANUAL CHEMICAL BYPASS FEEDER General Instructions Regarding All Models

INSTALLATION, OPERATION, AND MAINTENANCE MANUAL WELKER FILTER DRYER

The routine maintenance and inspection of local exhaust ventilation (LEV)

Cavitron DualSelect. Introduction ENGLISH. Directions For Use. Cavitron DualSelect Dispensing System ENGLISH 1

SOUTHBANK PLACE Asbestos Removal (Brief Guide)

CHAPTER 10 Reconstitution of Powdered Drugs

We appreciate the opportunity to submit these comments for your consideration.

M-System s I/P and P/I Transducers

Instructions For Use. Elastomeric Infusion Device

TEMPLE UNIVERSITY ENVIRONMENTAL HEALTH AND RADIATION SAFETY

Animal Biosafety Level 2

Regulatory Basics for Facility Design (WHO GMP): Current GMP Requirements

Air-Mate High Efficiency Powered Air Purifying Respirator (PAPR) Staff Training Module

Transcription:

Aseptic Processing Barrier Technology Trends with the Use of RABS and Isolators Barcelona, Spain October 27, 2015 Jack Lysfjord, Principal Consultant 952 546 2082 jlysfjord@q.com

Agenda Background - Diagrams Survey Data & Trends Q&A 2

Conventional Clean Room HEPA Filters Class 100 (ISO 5) Filling Mechanism Nozzle Vial Conveyor 3

4

RABS (Passive) Restricted Access Barrier System A barrier to prevent human intervention. Air flow provided by ceiling HEPAs to critical zone. Bottom of enclosure is open for air outlet. Glove ports and Transfer ports used for manipulations and commodity additions. Manual high level disinfection. 3-6" From HEPAS Class 10,000 (ISO 7) Class 100 (ISO 5) Nozzle Vial Conveyor HEPA Filters Filling Mechanism 5

RABS (Active) Restricted Access Barrier System Similar to Passive RABS but with integral HEPA/HVAC air supply to critical zone. Easiest way to have flow from critical area to room in case of open door intervention. Manual high level disinfection. Class 10,000 (ISO 7) Class 100 (ISO 5) Nozzle Vial Conveyor HEPA HVAC HEPA Filters Filling Mechanism 6

HEPA Closed RABS Manual high level disinfection. Can be Similar to an isolator without vapor biodecontamination. used for containment applications Class 10,000 (ISO 7) HEPA Filters Filling Mechanism Nozzle Vial Conveyor Air Return 7

RABS needs Management Oversight A Quality System Proper surrounding room design ISO 5 Annex for Open Door routine interventions Proper Gowning Proper Training cgmp Initial high level disinfection with Sporicidal agent Proper SOP for rare interventions allowed Properly Designed Equipment If interventions are allowed (Policy) Disinfection Line Clearance Documentation of event 8

9

10

Isolators 11

Isolator HEPA HEPA Filters Class 100,000 (ISO 8) Filling Mechanism Nozzle Vial Conveyor Air Return 12

13

14

15

Isolator for Containment HEPA Filters Bag In Bag Out Baffle Class 100,000 (ISO 8) Class 100 (ISO 5) CIP Filling Mechanism Nozzle Vial Conveyor Push Push HEPAS Sterilizable Drain for CIP 16

17

18

19

Data & Trends Data is from Lysfjord Porter Surveys Isolator 1998, 2000, 2002, 2004, 2006, 2008, 2010 and 2012 RABS 2005, 2007, 2009, and 2011 20

Filling Barriers Survey Summarys World Wide Year 1998 2000 2002 2004 2005 2006 2007 2008 2009 2010 2011 2012 Isolator 84 172 199 256 304 391 427 490 RABS 75 124 243 378 21

Barrier Isolator Filling Line Deliveries by Year Total 14 12 10 8 6 4 2 0 1985 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 22

Barrier Isolator Filling Lines Deliveries by Year - Asia Only 12 10 8 6 4 2 0 1985 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 23

Barrier Isolator Filling Lines Deliveries by Year - Europe Only 25 20 15 10 5 0 1985 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 24

Barrier Isolator Filling Lines Deliveries by Year - North America 25 Only 20 15 10 5 0 1985 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 25

Number of RABS Units Delivered by 70 Year Total 60 50 40 30 20 10 0 1990 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Asia Europe North America 26

RABS Delivered by Year by Continent - Asia 35 30 30 25 22 20 15 10 5 3 1 2 2 3 4 6 4 2 8 8 2 0 1990 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 27

RABS Delivered by Year by Continent - EUROPE 25 20 18 21 20 21 15 15 15 11 12 10 5 1 1 4 3 1 5 2 1 6 4 7 4 0 1990 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 28

RABS Delivered by Year by Continent 20 18 - North America 19 16 14 12 10 8 8 7 11 10 11 6 4 2 2 2 1 4 1 1 3 1 3 5 1 0 1990 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 29

Types of RABS Year Passive Active Closed Total 2005 15 25 17 57 2007 19 47 27 93 2009 51 121 64 236 2011 93 198 79 370 30

Philosophy for Using RABS DOORS 8% Open Frequently Year Never Opened Limited Open Frequently Open Total 2005 23 28 1 52 2007 26 45 6 77 2009 59 87 10 156 2011 89 133 19 241 31

Barrier Isolator Filling Lines Companies with Highest Usage Companies with more than 5 35 30 25 20 15 10 5 0 Sanofi Baxter Pfizer J&J GSK Novartis Taiyo Eli Lilly Nipropharma Boehringer Ingelheim S.A. Merck Apotex Astellas 32

Top Companies with RABS 2005 2007 2009 2011 # Company # of RABS Company # of RABS Company # of RABS Company # of RABS 1 Vetter 10 Vetter 10 Pfizer 17 Pfizer 18 2 Pfizer 7 Pfizer 10 Vetter 15 Vetter 18 3 Aventis 5 GSK 7 GSK 12 GSK 18 4 GSK 4 Aventis 5 Merck 11 Merck 18 33

Container Type Total - Global Vial Ampoule Syringe /Cartridge Ophthalmic IV Other Total 2012 Isolator 2011 RABS 218 48 99 18 32 19 434 234 27 77 16 3 9 366 34

Container Type Asia Vial Ampoule Syringe/ Cartridge Ophthalmic IV Other Total Isolator 2012 29 13 9 6 10 1 68 RABS 2011 20 2 8 7 3 40 35

Container Type EU Vial Ampoule Syringe/ Cartridge Ophthalmic IV Other Total Isolator 2012 100 28 72 4 1 12 217 RABS 2011 69 13 36 4 2 1 125 36

Container Type NA Vial Ampoule Syringe/ Cartridge Ophthalmic IV Other Total Isolator 2012 84 7 18 8 21 6 144 RABS 2011 47 4 9 2 62 37

Reported Number of Lines vs. Maximum Line Speed with Isolator 1-100 101-200 201-300 301-400 401-500 501-600 601-700 701-800 Total Total 135 49 65 46 6 16 5 322 Asia 19 4 12 7 42 EU 41 31 37 31 3 10 5 158 NA 74 14 16 6 3 6 119 38

Reported Number of Lines vs. Maximum Line Speed with RABS 1-100 101-200 201-300 301-400 401-500 501-600 601-700 701-800 Total Total 54 76 47 64 16 10 267 Asia 4 25 4 7 7 1 48 EU 33 37 36 34 8 5 153 NA 18 15 14 9 6 4 66 39

Gloves 2 nd Disposable Glove Used; Isolator 89% Yes, RABS 98% Yes Testing by Visual Inspection and Pressure Decay is Predominant Test for Both Isolator and RABS Replacement up to 6 months with As Needed most prevalent for Both Isolator & RABS 1 Piece 46%, 2 Piece 54%* Smooth Sleeve 85%, Pleats 15%* * Isolator data only 40

Containment Isolator, 108/228 Need Containment = 45% RABS, 16 Indicated a Containment Need 41

Do you Campaign Products (Isolator) (run for multiple days)? No Yes 51 35% of Total 94 65% of Total* Total 145 *65% was 51% in 2006 data 42

Campaign Products (longest run, Isolators) Total 25 20 15 10 5 0 2 3 4 5 6 7 8 10 12 14 16 20 21 28 # of Days 43

Number of Days Line Campaigned RABS 12 11 10 10 8 6 5 4 3 2 1 1 1 1 0 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 44

Trends Both Isolator and RABS Use Is Increasing Syringe in Tubs Is Rapidly Increasing in EU Isolator Containment Need is Increasing Especially with Isolator 94% of Isolators Use H2O2 As a Biodecontaminant Campaigning Use and Duration Are Both Increasing 28 days Isolator, 20 days RABS 45

Data Is Harder to Get Trends Continued RABS Problem; To Mount Sterile Stopper Feed Components Aseptically! Trend in EU (Bioquell and Steris), NA (Steris) and in Japan (Airex, JGC and Shibuya) Is to H2O2 Room with RABS and get 6 Log Reduction of Bioburden on Stopper Feed Parts RABS Problem; 8% of Doors Are Opened Frequently- Regulatory Issue! Jump in Rate of Deliveries for RABS 2009-2011 Due to Annex 1 Capping Change and CMO Retrofits on Existing Lines 46

Trends Continued So Which Best? Isolator or RABS? It Depends, on Application Needs. Both are Tools That Work, IF Used Properly. Keep Doors Closed on RABS. 47

Thank You! Jack Lysfjord, Principal Consultant 2711 Sylvan Road Minnetonka, MN 55305 USA +1(952) 546-2082 jlysfjord@q.com